Surgeons in China have successfully transplanted a genetically modified pig lung into a brain-dead human recipient, marking a first in xenotransplantation. The lung functioned for nine days, demonstrating that pig organs could potentially be used to address the global shortage of donor organs, which currently meets only about 10% of worldwide demand, according to the World Health Organization.
The Procedure and Findings
The left lung came from a Chinese Bama Xiang pig with six genetic modifications aimed at reducing the risk of rejection. It was transplanted into a 39-year-old male recipient, who was brain-dead. The lung remained viable over 216 hours without triggering hyperacute rejection, and no infection was observed. However, fluid buildup and progressive antibody-related damage emerged despite immunosuppressive treatment. Experts note that the presence of the recipient’s own lung may have masked the full impact of this damage.
Expert Analysis
Dr. Justin Chan of NYU Langone described the experiment as “exciting and promising” but emphasized it was a “qualified success” because the lungs could not independently sustain a patient. Andrew Fisher of Newcastle University called it an incremental step, noting the particular challenges of lung xenotransplantation due to constant exposure to the external environment and highly active immune defenses.
Peter Friend from Oxford University highlighted that brain death itself triggers inflammation, which may have affected the results. Researchers stressed that more work is needed to optimize immunosuppressive protocols, refine genetic modifications, and improve lung preservation strategies to ensure long-term function.
Future Directions
While lungs present unique challenges, xenotransplantation has seen success with other organs like kidneys, hearts, and livers. Other approaches being explored include:
- Remodeling human donor organs with stem cells.
- Growing humanized organs in pigs or sheep.
- Reconditioning human donor lungs previously deemed unsuitable for transplant.
Fisher noted that improving these alternative methods could provide practical solutions within months to years, offering a complementary path to addressing the organ shortage crisis while xenotransplantation techniques continue to advance.
